Alternative administration of paclitaxel-gemcitabine and paclitaxel-vinorelbine as first line treatment in NSCLC patients. A phase II study

7319 Background: Many trials have tested the efficacy of new cytotoxic agents in NSCLC patients. The alternative administration of two different schedules has rarely been attempted. Objective: The ...